| David Joseph Gaffin | EVP, CLO, Alkermes, Inc. | 225K | -4K | -6K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Blair Curtis Jackson | President & CEO, Alkermes plc | 124K | +218K | — | +139K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shane Cooke | — | 110K | — | +14K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Christian Todd Nichols | SVP, Chief Commercial Officer | 110K | — | — | +91K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| POPS RICHARD F | Director and CEO, Alkermes plc | 89K | — | — | +89K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Craig C. Hopkinson | EVP R&D, Chief Medical Officer | 78K | -18K | -27K | +113K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Joshua Reed | SVP, Chief Financial Officer | 66K | — | — | +97K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nancy Lynn Snyderman MD | — | 60K | -44K | +15K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Brian P Mckeon | — | 40K | — | +15K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Frank Anders Wilson | — | 37K | — | +15K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Richard Gaynor | — | 37K | — | +15K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cato T Laurencin | — | 35K | — | +15K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Christopher I Wright | — | 26K | — | +13K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Samuel Joseph Parisi | VP, Finance (Interim PAO) | 24K | — | -16K | +22K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nancy Lurker | — | 20K | — | +15K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |